3/20
06:15 pm
hae
What Investors Should Know About a $24 Million Exit From a Medical Device Stock Down 9% This Past Year [Yahoo! Finance]
Neutral
Report
What Investors Should Know About a $24 Million Exit From a Medical Device Stock Down 9% This Past Year [Yahoo! Finance]
3/11
11:53 am
hae
Haemonetics (HAE) had its price target lowered by Citigroup Inc. from $75.00 to $70.00. They now have a "neutral" rating on the stock.
Low
Report
Haemonetics (HAE) had its price target lowered by Citigroup Inc. from $75.00 to $70.00. They now have a "neutral" rating on the stock.
3/2
11:13 am
hae
Here's Why Haemonetics (HAE) is a Strong Value Stock [Yahoo! Finance]
Low
Report
Here's Why Haemonetics (HAE) is a Strong Value Stock [Yahoo! Finance]
2/23
04:15 pm
hae
Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology
Low
Report
Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology
2/20
04:05 pm
hae
Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference
Low
Report
Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference
2/18
01:22 am
hae
Haemonetics Corporation (HAE) Q3 Performance Prompts Baird Model Update, Price Target Falls to $81 [Yahoo! Finance]
Low
Report
Haemonetics Corporation (HAE) Q3 Performance Prompts Baird Model Update, Price Target Falls to $81 [Yahoo! Finance]
2/9
05:27 pm
hae
Chuck Royce's Strategic Moves: Significant Reduction in Haemonetics Corp [Yahoo! Finance]
Medium
Report
Chuck Royce's Strategic Moves: Significant Reduction in Haemonetics Corp [Yahoo! Finance]
2/6
12:00 pm
hae
Haemonetics (NYSE:HAE) was given a new $81.00 price target on by analysts at Robert W. Baird.
Low
Report
Haemonetics (NYSE:HAE) was given a new $81.00 price target on by analysts at Robert W. Baird.
2/6
09:09 am
hae
Haemonetics (NYSE:HAE) was given a new $94.00 price target on by analysts at Barrington Research.
Medium
Report
Haemonetics (NYSE:HAE) was given a new $94.00 price target on by analysts at Barrington Research.
2/6
09:09 am
hae
Haemonetics (NYSE:HAE) was given a new $80.00 price target on by analysts at Mizuho.
Medium
Report
Haemonetics (NYSE:HAE) was given a new $80.00 price target on by analysts at Mizuho.
2/6
08:04 am
hae
Haemonetics (NYSE:HAE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $88.00 price target on the stock.
Medium
Report
Haemonetics (NYSE:HAE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $88.00 price target on the stock.
2/6
07:17 am
hae
Haemonetics (NYSE:HAE) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
Haemonetics (NYSE:HAE) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
2/5
07:17 am
hae
Haemonetics GAAP EPS of $0.95 misses by $0.01, revenue of $338.9M beats by $6.18M [Seeking Alpha]
Low
Report
Haemonetics GAAP EPS of $0.95 misses by $0.01, revenue of $338.9M beats by $6.18M [Seeking Alpha]
2/5
06:00 am
hae
Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
Low
Report
Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
2/2
08:05 am
hae
Haemonetics (NYSE:HAE) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $93.00 price target on the stock.
Medium
Report
Haemonetics (NYSE:HAE) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $93.00 price target on the stock.
1/31
09:16 pm
hae
Haemonetics (HAE) Sparks Confidence Following Vivasure Acquisition [Yahoo! Finance]
Medium
Report
Haemonetics (HAE) Sparks Confidence Following Vivasure Acquisition [Yahoo! Finance]
1/12
08:34 am
hae
Haemonetics (NYSE:HAE) had its price target raised by analysts at Barrington Research from $90.00 to $93.00. They now have an "outperform" rating on the stock.
Low
Report
Haemonetics (NYSE:HAE) had its price target raised by analysts at Barrington Research from $90.00 to $93.00. They now have an "outperform" rating on the stock.
1/12
04:26 am
hae
EQT Life Sciences to exit Vivasure Medical via sale to Haemonetics [Yahoo! Finance]
Low
Report
EQT Life Sciences to exit Vivasure Medical via sale to Haemonetics [Yahoo! Finance]
1/12
01:48 am
hae
EQT Life Sciences to exit Vivasure Medical via sale to Haemonetics
Low
Report
EQT Life Sciences to exit Vivasure Medical via sale to Haemonetics
1/9
07:03 pm
hae
Vivasure Medical Announces Acquisition by Haemonetics Corporation [Yahoo! Finance]
Low
Report
Vivasure Medical Announces Acquisition by Haemonetics Corporation [Yahoo! Finance]
1/9
08:38 am
hae
Haemonetics (NYSE:HAE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $88.00 price target on the stock.
Medium
Report
Haemonetics (NYSE:HAE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $88.00 price target on the stock.
1/9
08:00 am
hae
Vivasure Medical Announces Acquisition by Haemonetics Corporation
Medium
Report
Vivasure Medical Announces Acquisition by Haemonetics Corporation
1/9
06:15 am
hae
Haemonetics Acquires Vivasure Medical Limited
Low
Report
Haemonetics Acquires Vivasure Medical Limited
1/7
06:17 pm
hae
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026
Low
Report
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026
1/2
06:00 am
hae
Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference